Tag: Prescription Drugs
Industry Payments Common Among Neurologists Prescribing MS Drugs
Nearly 80 percent of neurologists received payments; higher prescription volumes linked to higher receipt of payments
Azelastine Nasal Spray Reduces Risk for SARS-CoV-2 Infection
Azelastine also shows increase in mean time to SARS-CoV-2 infection, reduction in symptomatic infections
Many Preschoolers Receive ADHD Medications Within 30 Days of Diagnosis
Asian, Hispanic, and Black children less likely to be prescribed medication early compared with White children
β-Blockers Not Beneficial After MI Without Reduced Left Ventricular Ejection Fraction
Second study shows beneficial effects for patients with myocardial infarction and mildly reduced LVEF
Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI
Incidence of primary end point of death, MI, heart failure hospitalization up with beta-blockers in women, but not in men
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
Cannabis-Based Medical Products Aid Primary Insomnia
Findings seen in as little as one month of treatment through 18 months of treatment
FDA Now Providing Daily Updates on Adverse Events
To increase transparency, the agency is publishing data from the FDA Adverse Event Reporting System daily rather than quarterly
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
No reduction seen in the composite outcome of cardiovascular mortality, hospitalization due to heart failure
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
However, disparities exist among cancer survivors by race and health coverage
